| 000 | 01770 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515233205.0 | ||
| 264 | 0 | _c20110208 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1365-2982 | ||
| 024 | 7 |
_a10.1111/j.1365-2982.2010.01571.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrueger, D | |
| 245 | 0 | 0 |
_aSignaling mechanisms involved in the intestinal pro-secretory actions of hydrogen sulfide. _h[electronic resource] |
| 260 |
_bNeurogastroenterology and motility _cNov 2010 |
||
| 300 |
_a1224-31, e319-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xphysiology |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aDiffusion Chambers, Culture |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Sulfide _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIntestines _xdrug effects |
| 650 | 0 | 4 |
_aJejunum _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeurons, Afferent _xdrug effects |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xphysiology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSubstance P _xphysiology |
| 650 | 0 | 4 |
_aSulfides _xpharmacology |
| 650 | 0 | 4 |
_aTRPV Cation Channels _xantagonists & inhibitors |
| 700 | 1 | _aFoerster, M | |
| 700 | 1 | _aMueller, K | |
| 700 | 1 | _aZeller, F | |
| 700 | 1 | _aSlotta-Huspenina, J | |
| 700 | 1 | _aDonovan, J | |
| 700 | 1 | _aGrundy, D | |
| 700 | 1 | _aSchemann, M | |
| 773 | 0 |
_tNeurogastroenterology and motility _gvol. 22 _gno. 11 _gp. 1224-31, e319-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2982.2010.01571.x _zAvailable from publisher's website |
| 999 |
_c19999485 _d19999485 |
||